Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Article Type
- Review1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset)1
-
Year
- Journal Title
- Adv Chromatogr1
Search Results
Sort by
- Bookedited by Juliano Cerci, Stefano Fanti, Dominique Delbeke.Contents:
PART I. Biopsy guided PET/CT: Principle of biopsy guided imaging
FDG PET/CT to guide biopsy: methods
FDG PET/CT to guide biopsy: type of acess
PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma
FDG PET/CT to guide biopsy in lymphoma: results
PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions
FDG PET/CT to guide biopsy in pancreatic lesions: results
PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions
FDG PEM to guide biopsy in breast lesions: results
PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies
FDG PET/CT to guide biopsy in CNS: results
PART VI. PET/CT and prostate cancer
Choline PET/CT to guide biopsy in prostate cancer diagnosis
PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results. - ArticleNelson JA.Adv Chromatogr. 1977;15:273-305.Through specific examples, the versatility of HSLC in clinical and pharmacological studies has been demonstrated. These examples are not intended to restrict the vision of the reader, like that of the author, but on the contrary, it is hoped that those not yet familiar with the usefulness of HSLC will gain perspective concerning this technique in their own fields of interest. The virtually unlimited ability to separate cellular metabolites (or other organic compounds for that matter) by HSLC is a reality at this time; however, development of more selective, sensitive means of detection and positive identification of eluting components is needed, similar to that gained by coupling mass spectrometry with gas chromatography.